Bendamustime: A Viewpoint by Patrick Schöffski and Arnold Ganser

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.5, 2001-01, pp. : 639-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basiliximab: A Viewpoint by Björn Nashan

By Nashan B.

Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. : 214-214

Adis International

Access to resources Recommend Favorite

Memantine: A Viewpoint by Hans Förstl

By Förstl H.

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 477-478

Adis International

Access to resources Recommend Favorite

Leukapheresis was effective in the treatment of a child with Henoch-Schönlein purpura

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

BCG: Henoch-Schönlein purpura following intravesical administration in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1084, 2006-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Isotretinoin: Henoch-Schönlein purpura (first report)?: case report

Reactions Weekly, Vol. 1, Iss. 1257, 2009-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite